These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 10336510

  • 1. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
    Damaj MI, Slemmer JE, Carroll FI, Martin BR.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
    [Abstract] [Full Text] [Related]

  • 2. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity.
    Damaj MI, Flood P, Ho KK, May EL, Martin BR.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):780-5. PubMed ID: 15356218
    [Abstract] [Full Text] [Related]

  • 3. Influence of gender and sex hormones on nicotine acute pharmacological effects in mice.
    Damaj MI.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):132-40. PubMed ID: 11123373
    [Abstract] [Full Text] [Related]

  • 4. Bupropion is a nicotinic antagonist.
    Slemmer JE, Martin BR, Damaj MI.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
    [Abstract] [Full Text] [Related]

  • 5. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
    Damaj MI, Glassco W, Aceto MD, Martin BR.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):390-8. PubMed ID: 10490929
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.
    Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1425-34. PubMed ID: 9316856
    [Abstract] [Full Text] [Related]

  • 7. Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
    Reichel CM, Linkugel JD, Bevins RA.
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):501-9. PubMed ID: 17924784
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of nicotine-induced seizures in mice.
    Damaj MI, Glassco W, Dukat M, Martin BR.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1284-91. PubMed ID: 10565853
    [Abstract] [Full Text] [Related]

  • 9. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.
    Brain Res; 2006 Oct 30; 1117(1):18-24. PubMed ID: 16949560
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
    Carroll FI, Hu X, Navarro HA, Deschamps J, Abdrakhmanova GR, Damaj MI, Martin BR.
    J Med Chem; 2006 Jun 01; 49(11):3244-50. PubMed ID: 16722642
    [Abstract] [Full Text] [Related]

  • 11. In vivo characterization of a novel inhibitor of CNS nicotinic receptors.
    Damaj MI, Wiley JL, Martin BR, Papke RL.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):43-8. PubMed ID: 16181622
    [Abstract] [Full Text] [Related]

  • 12. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep 03; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 13. Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration.
    Carroll FI, Fox BS, Kuhar MJ, Howard JL, Pollard GT, Schenk S.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):149-56. PubMed ID: 17067572
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine.
    Martin TJ, Suchocki J, May EL, Martin BR.
    J Pharmacol Exp Ther; 1990 Jul 28; 254(1):45-51. PubMed ID: 2366189
    [Abstract] [Full Text] [Related]

  • 15. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ, Ye J, Li CL, Li RT, Sun Q.
    Pharmacol Biochem Behav; 2007 Apr 28; 86(4):643-50. PubMed ID: 17379285
    [Abstract] [Full Text] [Related]

  • 16. Involvement of calcium and L-type channels in nicotine-induced antinociception.
    Damaj MI, Welch SP, Martin BR.
    J Pharmacol Exp Ther; 1993 Sep 28; 266(3):1330-8. PubMed ID: 7690401
    [Abstract] [Full Text] [Related]

  • 17. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat.
    Cook CD, Carroll IF, Beardsley PM.
    Psychopharmacology (Berl); 2001 Dec 28; 159(1):58-63. PubMed ID: 11797070
    [Abstract] [Full Text] [Related]

  • 18. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
    Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR.
    J Pharmacol Exp Ther; 1998 Mar 28; 284(3):1058-65. PubMed ID: 9495867
    [Abstract] [Full Text] [Related]

  • 19. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL, Kopajtic TA, Agoston GE, Newman AH.
    J Pharmacol Exp Ther; 2004 May 28; 309(2):650-60. PubMed ID: 14755006
    [Abstract] [Full Text] [Related]

  • 20. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
    Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR.
    Mol Pharmacol; 2004 Sep 28; 66(3):675-82. PubMed ID: 15322260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.